[Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review]

Rev Med Interne. 2020 Mar;41(3):200-205. doi: 10.1016/j.revmed.2019.12.018. Epub 2020 Jan 21.
[Article in French]

Abstract

Introduction: Chronic enterovirus infections can occur in primary immunodeficiency with hypogammaglobulinemia. They usually associate meningitis and myofasciitis. Such infections have also been described in adults with rituximab-induced hypogammaglobulinemia.

Case report: We report the case of a 33-year-old woman who was given rituximab for immune thrombocytopenia and developed rituximab-induced hypogammaglobulinemia (IgG 4.4g/L). One year after the last rituximab infusion, she developed lower limbs myofasciitis, followed two months later by a chronic lymphocytic meningitis. PCR in the serum and the cerebrospinal fluid at the time of the meningitis and the myofasciitis were positive to the same enterovirus (echovirus 11) while it was negative in the fascia biopsy. Under treatment with intravenous immunoglobulins, all symptoms and laboratory abnormalities improved and enterovirus PCR became negative.

Conclusion: We report a case of chronic enterovirus infection associating meningitis and myofasciitis in an adult with rituximab-induced hypogammaglobulinemia. Outcome was favorable under treatment with intravenous immunoglobulins.

Keywords: Enterovirus; Entérovirus; Hypogammaglobulinemia; Hypogammaglobulinémie; Meningitis; Myofasciite; Myofasciitis; Méningite; Rituximab.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Agammaglobulinemia / chemically induced*
  • Agammaglobulinemia / virology
  • Chronic Disease
  • Enterovirus Infections / chemically induced*
  • Enterovirus Infections / immunology
  • Enterovirus Infections / therapy
  • Fasciitis / chemically induced
  • Fasciitis / therapy
  • Female
  • France
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Meningitis / chemically induced
  • Meningitis / complications
  • Meningitis / therapy
  • Myositis / chemically induced
  • Myositis / complications
  • Myositis / therapy
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy
  • Rituximab / adverse effects*

Substances

  • Immunoglobulins, Intravenous
  • Rituximab